Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine composition for washing nasal cavity and preparation method of medicine composition

A composition and drug technology, applied in the direction of drug combination, drug delivery, pharmaceutical formulation, etc., to achieve the effects of stable curative effect, accelerated recovery of health, and clear effect

Inactive Publication Date: 2018-04-13
四川清舒乐科技有限公司
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] There has not been any report that the external use of lysozyme to rinse the nasal cavity is used to dilute and clean nasal inflammation secretions, harmful air pollutants adsorbed by nasal mucus, dissolve some bacteria and viruses, clean various bacteria and viruses, improve the physiological environment of the nasal cavity, and achieve the treatment of nasal congestion, Runny nose, bloody nose, reflux, sneezing, nasal scab, dry itchy nose, foreign body sensation in the throat, excessive phlegm, expectoration, bloody sputum, throat inflammation and other precedents of nasal and upper respiratory tract infections

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for washing nasal cavity and preparation method of medicine composition
  • Medicine composition for washing nasal cavity and preparation method of medicine composition
  • Medicine composition for washing nasal cavity and preparation method of medicine composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0049] The following describes but does not limit the present invention through the description of specific embodiments of the present invention.

[0050] During two years of clinical application, the inventor adjusted the dosage of the crude drug within the following weight ratio range, all of which could achieve the treatment of nasal congestion, runny nose, bloody nose, backflow of nasal mucus, sneezing, scab in the nasal cavity, dry and itchy nasal cavity, throat Various nasal cavity and upper respiratory tract infections such as foreign body sensation, excessive phlegm, expectoration, bloody sputum, throat inflammation, etc.: the weight ratio of raw materials is 35-75 parts of sodium chloride, 1-4 parts of lysozyme or sodium chloride 35-85 parts, 0.1-0.5 parts of glycine, 1-4 parts of lysozyme.

[0051] For the convenience of application, on the basis of raw materials, pharmaceutically acceptable excipients can be added to make common powders, lotions, concentrates, spray...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicines, health care and nursing, and relates to a medicine composition for washing a nasal cavity and a preparation method of the medicine composition. The medicine composition can dilute and clean inflammatory secretions of the nasal cavity and harmful air pollutants adsorbed by nasal mucus, dissolve part of pathogenic bacteria and viruses, clean various germs and viruses and improve the physiological environment of the nasal cavity to fulfill the aims of treating various nasal infections and upper respiratory tract infections such as nasal obstruction, rhinorrhea, blood-stained nasal discharge, postnasal drip, sneezing, nasal incrustation, dry and itching nasal cavity, foreign body sensation in the throat, excessive phlegm, expectoration, blood-stained sputum and sphagitis. The medicine composition disclosed by the invention is prepared by mixing 35 to 75 weight parts of sodium chloride and 1 to 4 weight parts of lysozyme, or 35 to 85 weight parts of sodium chloride, 0.1 to 0.5 weight part of glycine and 1 to 4 weight parts of lysozyme. The medicine composition can improve the physiological environment of the nasal cavity more quickly andaccelerate recovery of the nasal cavity. The medicine composition has the advantages of definite effect, stable curative effect, controllability and the like.

Description

technical field [0001] The invention belongs to the fields of medicine, health care and nursing, and relates to a pharmaceutical composition for flushing nasal cavity and a preparation method thereof. The medicinal composition can dilute and clean nasal inflammation secretions, harmful air pollutants adsorbed by nasal mucus, dissolve some germs and viruses, clean various bacteria and viruses, improve the physiological environment of the nasal cavity, and achieve the treatment of nasal congestion, runny nose, bloody nose, and nasal mucus Regurgitation, sneezing, scab in the nasal cavity, dry and itchy nasal cavity, foreign body sensation in the throat, excessive phlegm, coughing up sputum, blood in the sputum, throat inflammation and other nasal cavity and upper respiratory tract infections. Background technique [0002] For colds, rhinitis, sinusitis and other acute and chronic infections of the nasal cavity caused by nasal congestion, runny nose, bloody nasal mucus, backflo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/47A61K47/18A61K47/02A61P11/02A61P7/04A61P11/04A61P11/10A61P11/00A61P31/02A61P31/04A61P31/12
CPCA61K9/0043A61K38/47A61K47/02A61K47/183A61K2300/00
Inventor 刘丽
Owner 四川清舒乐科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com